Lineage director granted 4,490 RSUs in stock award
Turner Michael John reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Turner Michael John reported acquisition or exercise transactions in this Form 4 filing.
Lineage, Inc. disclosed that director Michael John Turner received a grant of 4,490 shares of Common Stock as a stock award with no cash paid per share. After this grant, he directly holds 11,612 shares.
The footnote explains this is a grant of time-based restricted stock units (RSUs), which are contingent rights to receive common shares on a one-for-one basis. These RSUs vest in full on the earlier of June 9, 2027, or the date of the next annual meeting of stockholders following June 9, 2026, if he continues to serve the company through that date.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 4,490 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents the grant of time-based restricted stock units ("RSUs"), which are contingent rights to receive shares of common stock on a one-for-one basis and which vest in full on the earlier to occur of (i) June 9, 2027, and (ii) the date of the next annual meeting of the Company's stockholders following June 9, 2026, subject to continued service with the Issuer through such applicable date.
Key Figures
Key Terms
restricted stock units financial
RSUs financial
contingent rights financial
time-based financial
annual meeting of the Company's stockholders financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Lineage, Inc. (LINE) director Michael John Turner receive in this Form 4?
What are the vesting terms of Michael John Turner’s RSUs at Lineage, Inc. (LINE)?
Is Michael John Turner’s Lineage, Inc. RSU grant a cash transaction?
How is the size of Michael John Turner’s RSU grant at Lineage, Inc. described?
AI-generated analysis. How Rhea-AI works. Not financial advice.